1. Home
  2. XYLO vs SINT Comparison

XYLO vs SINT Comparison

Compare XYLO & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • SINT
  • Stock Information
  • Founded
  • XYLO 1999
  • SINT 1996
  • Country
  • XYLO Israel
  • SINT United States
  • Employees
  • XYLO N/A
  • SINT N/A
  • Industry
  • XYLO
  • SINT Medical/Dental Instruments
  • Sector
  • XYLO
  • SINT Health Care
  • Exchange
  • XYLO NYSE
  • SINT Nasdaq
  • Market Cap
  • XYLO 2.2M
  • SINT 2.2M
  • IPO Year
  • XYLO N/A
  • SINT 2014
  • Fundamental
  • Price
  • XYLO $3.08
  • SINT $2.76
  • Analyst Decision
  • XYLO
  • SINT Hold
  • Analyst Count
  • XYLO 0
  • SINT 1
  • Target Price
  • XYLO N/A
  • SINT N/A
  • AVG Volume (30 Days)
  • XYLO 21.9K
  • SINT 48.8K
  • Earning Date
  • XYLO 11-29-2024
  • SINT 11-12-2024
  • Dividend Yield
  • XYLO N/A
  • SINT N/A
  • EPS Growth
  • XYLO N/A
  • SINT N/A
  • EPS
  • XYLO N/A
  • SINT N/A
  • Revenue
  • XYLO $57,642,000.00
  • SINT $3,247,000.00
  • Revenue This Year
  • XYLO N/A
  • SINT $10.77
  • Revenue Next Year
  • XYLO N/A
  • SINT $19.38
  • P/E Ratio
  • XYLO N/A
  • SINT N/A
  • Revenue Growth
  • XYLO N/A
  • SINT 30.40
  • 52 Week Low
  • XYLO $2.70
  • SINT $2.01
  • 52 Week High
  • XYLO $10.43
  • SINT $105.80
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 41.43
  • SINT 47.65
  • Support Level
  • XYLO $2.71
  • SINT $2.01
  • Resistance Level
  • XYLO $3.13
  • SINT $3.12
  • Average True Range (ATR)
  • XYLO 0.33
  • SINT 0.25
  • MACD
  • XYLO -0.06
  • SINT -0.05
  • Stochastic Oscillator
  • XYLO 16.56
  • SINT 57.69

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: